Lotte Biologics signs antibody drug CMO deal with UK’s Ottimo Pharma
BOSTON – Lotte Biologics Co. has signed a deal to manufacture an antibody therapy for British biotech startup Ottimo Pharma as the South Korea...
Samsung, Celltrion lead biosimilar market in Europe, US
Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...
Celltrion seeks large-scale M&A in Q4, eyes 2027 Nasdaq debut
SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...
Celltrion’s Remsima on course to become Korea’s 1st blockbuster drug
Celltrion Inc.'s Remsima, the world’s first biosimilar monoclonal antibody, is on track to exceed 1 trillion won ($713 million) in sales this ...
Hyundai Motor Group six affiliates to strengthen carbon neutrality
Hyundai Motor Group said on Monday that six affiliates and Hyundai Engineering & Construction Co. signed a memorandum of understanding (MOU) for...
Celltrion to establish CDMO subsidiary
Celltrion Inc., South Korea’s largest biosimilar maker, said on Friday it plans to establish a contract development and manufacturing organiza...
Celltrion eyes M&A in Europe, $3.3 bn Zymfentra sales: chairman
WASHINGTON, D.C. – South Korean biosimilar giant Celltrion Inc. is accelerating its push to transform into a novel drug developer, going after...
KEXIM, US DOE to support S.Korean green energy firms
The Export-Import Bank of Korea (KEXIM) said on Mar. 7 that it will support domestic firms that aim to enter the American green energy industry with...
CJ OnStyle launches genderless fashion brand M12
South Korea's CJ OnStyle announced on Thursday that it will launch a genderless fashion brand M12. M12 means genderless lifewear that can be worn co...
Celltrion, WuXi XDC to develop new antibody-drug conjugates
South Korea’s Celltrion Inc. has signed a business agreement with China’s WuXi XDC to jointly develop new antibody-drug conjugates (ADC)...
Lotte Biologics, NJ Bio to jointly develop ADC
South Korea's Lotte Biologics Co. announced on Monday that it has signed a strategic business agreement with NJ Bio, a US-based preclinical and clin...
Orion to buy control of biotech startup LegoChem for $415 mn
South Korea’s snack and confectionery maker Orion Group has agreed to buy a controlling stake in LegoChem Biosciences Inc., a Korean biotech s...
Celltrion, Cyron to develop multi-specific antibody new drug
South Korea’s biopharmaceutical company Celltrion Inc. announced on Wednesday that it signed a joint research agreement with domestic startup ...
Hyundai Motor signs Korea’s largest PPA deal to go carbon neutral
South Korea’s top automaker Hyundai Motor Co. said on Thursday it has signed a power purchase agreement (PPA) with Hyundai Engineering & C...
'World-class bispecific antibody technology of ABL Bio'
MADRID - "The clinical Phase 1 results of the immune-oncology candidate ABL111, developed in collaboration with ABL Bio, have been selected as the b...
Lotte builds US antibody-drug conjugate plant with $82 mn
South Korea’s Lotte Biologics Co. is establishing an antibody-drug conjugate (ADC) factory in Syracuse, New York, with an investment of 110 bi...
DL E&C, Saudi SWCC team up for carbon neutrality
South Korea's DL E&C Co. announced on Monday it signed a memorandum of understanding (MOU) for the application of small modular reactors (SMRs) ...
HLB gets global rights to Chinese liver cancer drug
South Korea’s HLB Therapeutics Co. on Tuesday said its US subsidiary Elevar Therapeutics has acquired the global rights excluding South Kore...
Hyundai Glovis pledges carbon neutrality by 2045
South Korean shipping and logistics company Hyundai Glovis Co. on Thursday pledged to achieve carbon neutrality by 2045. Despite producing a h...
Samsung Electronics on track to achieve carbon neutrality by 2050
Come Friday, Samsung Electronics Co., the world’s largest memory chipmaker, will mark its first anniversary of publicly announcing its enterpr...
Hanmi Pharm to start global clinical trials for immune-oncology drug
South Korea's Hanmi Pharmaceutical Co. announced on Tuesday that it has received approval for the phase 1 clinical trial plan of the immune-oncology...
Hyundai partners with 5 universities for carbon neutrality center
In a bid to accelerate the development of carbon-neutral technologies, Hyundai Motor Group has joined forces with prominent domestic universities.Th...
Hyundai Steel to open carbon-neutral steel lab by 2023
Hyundai Steel Co., a unit under South Korean auto giant Hyundai Motor Group, is set to kick off research on hydrogen-based steelmaking as its new la...
POSCO Int'l to cut carbon emissions 37% by 2030
South Korea's largest trading company POSCO International on Sunday said it officially declared its goal of achieving carbon neutrality by 2050 to b...
SK Siltron to collaborate with Taiwan's Nanya on carbon neutrality
South Korea's SK Siltron announced on Tuesday that it has signed a business agreement with Taiwan's DRAM supplier Nanya Technology Corporation to st...
POSCO readies for leap to carbon-neutral steel
South Korea’s POSCO Group is preparing to produce carbon-neutral steel, using hydrogen instead of fossil fuels such as coal and natural gas, w...
Korea starts building Shin Hanul, reviving aim to be nuclear powerhouse
South Korea has begun construction of the main parts of the Shin Hanul nuclear reactors No. 3 and No. 4, reviving its goal of becoming a global nucl...
HD KSOE declares carbon neutrality in first for S.Korea's shipbuilders
South Korea's HD Korea Shipbuilding & Offshore Engineering (HD KSOE), the shipbuilding holding company of HD Hyundai Co., is the first in domest...
Korea’s SK Gas to invest $1.5 bn toward carbon neutrality by 2026
ULSAN – SK Gas Ltd. South Korea’s leading liquefied petroleum gas (LPG) supplier, is set to spend $1.5 billion on liquefied natural gas ...
Hyundai Steel unveils carbon neutrality roadmap
South Korea's steelmaker Hyundai Steel unveiled on Wednesday its "Carbon Neutrality Roadmap" aimed at reducing its direct and indirect carbon emissi...
